Previous Article | Next Article ![]()
Infection and Immunity, July 2008, p. 3093-3099, Vol. 76, No. 7
0019-9567/08/$08.00+0 doi:10.1128/IAI.01627-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas 66160
Received 7 December 2007/ Returned for modification 20 January 2008/ Accepted 25 April 2008
|
|
|---|
|
|
|---|
Streptococcus mutans, which resides in the human oral cavity, is the primary causative organism of dental caries, an important and economically costly human disease. This pathogenic bacterium exhibits a biofilm lifestyle when residing in dental plaque, a highly dense and diverse bacterial community that forms on the tooth surface (28). S. mutans displays several unique mechanisms that enable it to survive and persist in dental plaque (3, 24). For example, the ability to produce and bind to extracellular polysaccharides such as glucan allows S. mutans to colonize and to maintain a dominant presence in the oral plaque (5). Glucan is a polymer of glucose that is synthesized by S. mutans from the disaccharide sucrose ingested by its host through the activity of various glucosyltransferases (Gtfs) (5, 54). A significant constituent of the plaque biofilm is water-insoluble glucans, which are formed primarily through the activity of GtfB/GtfC (54). S. mutans also expresses at least four glucan binding proteins (Gbps) on the cell surface, which directly binds to the glucans produced by the bacterium (4, 5, 41, 44, 47). The adhesive nature of glucans, along with the surface-associated Gbps, facilitates the adherence and accumulation of this bacterium as a stable biofilm on the tooth surface.
Among all the Gbps, GbpC appears to be the most important, since it is directly involved in biofilm formation and cariogenicity of S. mutans (41). GbpC has also been shown to be involved in the rapid dextran-dependent aggregation of bacteria (41). The dextran-dependent aggregation phenotype is growth phase independent and was not observed under standard growth conditions; however, this phenotype was induced in cells grown under various stress conditions (41, 43). The results of a recent expression study suggest that the presence of sucrose in growth medium induces low levels of repression of gbpC expression, while the presence of other carbohydrates had little to no effect on gbpC expression (7). Maximal expression of gbpC is observed at the mid-exponential growth phase, but the gbpC transcript produced is unstable, with a short half-life of less than 2 min (7). Expression of the gbpC gene is also dependent on the growth temperature as well as the pH of the growth medium (7). Moreover, the expression of gbpC is also under the transcriptional control of CovR (7, 42), a global response regulator that regulates virulence factors in many streptococci. CovR represses the expression of gbpC by directly binding to the promoter region and preventing binding by RNA polymerase.
While we are beginning to gain further insight into the regulation of gbpC expression, the environmental signals that induce the expression of gbpC and the sensor kinase(s) that receives the signal are currently unknown. S. mutans encodes a total of 14 TCS systems (8), some of which are involved in the synthesis of glucans and the expression of Gbps (7, 10, 21). In this communication, we studied the roles of all 14 sensor kinases in the regulation of gbpC expression and found that LiaS represses gbpC transcription. Furthermore, our studies revealed that LiaS also activates the production of mutacin IV, which is also under the control of a common regulatory network along with gbpC.
|
|
|---|
was grown in Luria-Bertani medium supplemented, when necessary, with ampicillin (100 µg/ml), erythromycin (300 µg/ml), kanamycin (100 µg/ml), and/or spectinomycin (100 µg/ml). S. mutans UA159 and its derivatives were used for all genetic experiments. The various S. mutans strains were routinely grown in Todd-Hewitt medium (BBL; Becton Dickson) supplemented with 0.2% yeast extract (THY). When necessary, erythromycin (10 µg/ml), chloramphenicol (10 µg/ml), kanamycin (300 µg/ml), and/or spectinomycin (300 µg/ml) was added to the sterile growth medium. Construction of sensor kinase deletion strains. The wild-type transcriptional reporter strain IBS131, which contains the PgbpC-gusA fusion construct inserted at the SMu1405 locus of its genome (7), was used for the in vivo analysis of the inactivated sensor kinase genes. Internal fragments (approximately 500 bp) corresponding to the open reading frames of 14 putative sensor kinase genes were cloned into pBSKEry (9) to generate 14 mutagenic plasmids; these plasmids were previously described in detail by Biswas et al. (8) and were used to systematically inactivate the corresponding sensor kinase genes in IBS131 via natural transformation. The resulting mutant strains were confirmed by PCR analysis using flanking primers as described previously (8). The names of the various strains generated, along with the corresponding mutated sensor kinases, are listed in Table 1.
|
View this table: [in a new window] |
TABLE 1. S. mutans strains used in this study
|
![]() View larger version (14K): [in a new window] |
FIG. 2. Schematic diagram illustrating the deletions performed on the loci coding for the SMu486/SMu487 TCS in S. mutans UA159. Open reading frames and orientations of transcription are indicated with block arrows. The locations of the DNA sequence fragments that were used for insertion mutagenesis (pIB14) and construction of the complementing plasmid pIB55 are indicated by horizontal lines below SMu486/SMu487. The SMu486, SMu487, and SMu486/SMu487 genes were deleted and replaced with the spectinomycin resistance gene aad (Sp).
|
For the simultaneous deletion of both SMu486 and SMu487 (
liaSR), a 2.43-kb fragment spanning both open reading frames was PCR amplified from UA159 genomic DNA using primers Bam-Smu486-F1 and Bam-Smu487-R2 and cloned into the pGemT-Easy vector to generate pIB66. The aad9 gene was then cloned into XhoI-BbsI-digested/T4 polymerase-blunted pIB66 to generate pIB68. The SMu486/SMu487 (liaSR) locus was inactivated after the transformation of strains UA159 and IBS131 with NotI-linearized pIB68, generating strains IBS183 and IBS155, respectively (see Fig. 2).
To determine whether the expression of SMu487 leads to the regulation of gbpC expression, wild-type strain IBS131 was transformed with pIB181 or pIB169, pJRS1315 derivatives with or without SMu487, respectively. Briefly, SMu487 was amplified from genomic DNA from wild-type UA159 using EcoR-Smu487-F1 (5'-GCGGAATTCATGCTGATGAGTAAAACAAAAGTTATACTGG-3') and Bam-Smu487-R2 (CGCGGATCCTTTAGCACCTGCTTCAATGACAGG) and cloned into EcoRI-BamHI-digested pIB169, which contains the Pveg promoter, the vegetative promoter of Bacillus. The resulting plasmid contained a Pveg-SMu487 fusion and was designated pIB181.
Semiquantitative RT-PCR. Total RNA samples were isolated from liquid cultures at different growth phases for analyses of gbpC transcript levels. The isolation of RNA from liquid culture was performed as described previously (7). Since the production of mutacin IV was analyzed by monitoring the growth of the various strains on solid medium, total RNA samples were isolated from cultures grown on THY agar to measure nlmA or nlmT transcript levels. For the isolation of RNA from solid medium, THY agar plates containing appropriate antibiotics, if required, were inoculated with UA159 or its derivatives and grown overnight at 37°C at 5% CO2. Samples were collected by scraping the cultures from the agar plates and resuspending the bacterial biomass in RNAProtect solution (Qiagen); RNA was purified according to the supplier's suggested protocol. The RNA concentrations were determined by UV spectrophotometry, in addition to Bioanalyzer analysis. Semiquantitative analyses of transcript levels of various genes, as well as gyrA (as control), were performed by use of a one-step reverse transcription (RT)-PCR assay using the Titan One Tube RT-PCR system (Roche) as described previously (7). Fifty nanograms of RNA was used for each RT-PCR, analyzed in 1% agarose gel, and quantitated using Doc-It-LS software (UVP).
The primers specific for the gbpC transcript (GbpC-F5 and GbpC-R2) (7) produce a 308-bp PCR product, the primers specific for the nlmA transcript (NlmAF1 [5'-ATGGATACACAGGCATTTGAACAATTTGATGTA-3'] and NlmAR1 [5'-TGAGATCGAATGAGTCCCCAAGTGCCTA-3']) produce a 200-bp PCR product, and the primers specific for the nlmT transcript (NlmTF [5'-TTAATCGTCATAGCCGTTAACATTCTCTTAGAGA-3'] and NlmTR [5'-CCTTACTCATCCTAGTCACCTTAACTGAAGGAT-3']) produce a 481-bp PCR product. The primers specific for the gyrA transcript (GyrA For and Gyr Rev) (7) generate a 470-bp PCR product. Expression of the gyrA gene served as an internal control to ensure that equal amounts of RNA were used in all RT-PCRs.
GusA assays. β-Glucuronidase (Gus) assays were performed after the S. mutans cultures reached the mid-exponential growth phase (70 Klett units) (9) as described previously by Biswas and Biswas (10). The activities of the culture lysates were quantified by comparison with the activity of glucuronidase standards (Sigma-Aldrich). The protein concentration of the lysate was determined using a Micro BCA protein assay kit (Pierce) standardized with bovine serum albumin (Sigma).
Deferred antagonism assay. Deferred antagonism assays were used to evaluate the production of mutacin IV by the S. mutans cultures (8). Mutacin IV-producing tester strains were stabbed into THY agar plates and grown overnight at 37°C under anaerobic conditions. Streptococcus gordonii DL-1 and Streptococcus cristatus 5100 were used as indicator strains. These strains were grown in THY broth; 0.4 ml of each culture was mixed with 4 ml of soft agar (0.4%) and poured over the surface of the THY agar plate stabbed with the tester strains. The inoculated plates were incubated overnight at 37°C under anaerobic conditions, and the diameter of the zone of inhibition around the mutacin-producing strains was measured the following morning.
|
|
|---|
500 bp) derived from each of the sensor kinase genes were cloned into suicide vector pBSKEry (9) to generate 14 inactivating plasmids (8) for the transformation of IBS131. Sensor kinase mutants were systematically generated through single-crossover chromosomal integration of the inactivating plasmid at the specific sensor kinase locus. Transcription from PgbpC was then measured in the wild type and 14 sensor kinase mutant strains by assaying the GusA activity produced from PgbpC-gusA. Only one sensor kinase mutant, SMu486 (IBS339), exhibited increased activity (
2.2-fold) compared to that of wild-type strain IBS131 (Fig. 1). The Gus activity for the other sensor kinase mutants was similar to that of the wild-type strain. Taken together, the results suggest that SMu486 represses expression from PgbpC, either directly or through an interaction with another system; no other sensor kinase appears to be associated with the regulation of expression from PgbpC.
![]() View larger version (37K): [in a new window] |
FIG. 1. Expression from PgbpC-gusA in the sensor kinase mutants. Fourteen different sensor kinases were inactivated in IBS131 in order to measure their effect on PgbpC-gusA expression. Strains were grown in THY broth at 37°C and harvested at the mid-exponential phase, and gusA activity was measured. The values were normalized with Gus activity obtained with IBS131. Experiments were repeated at least twice, and the mean values are shown.
|
The inactivation of liaS via single-crossover chromosomal integration with plasmid pIB14 (Table 1) may have a polar effect on the downstream liaR gene, which encodes the cognate response regulator. To eliminate the possibility of polar effects, nonpolar mutants of liaS and liaR were generated by direct gene replacement. Expression of liaR in the single- and double-crossover liaS mutants was confirmed by RT-PCR analysis; the levels of liaR transcript did not differ in either mutant (data not shown). Both liaS and liaR were simultaneously inactivated to study whether this TCS is involved in the expression of gbpC. Gus activity from the wild-type,
liaS,
liaR, and
liaSR strains was measured. We observed that nonpolar mutant strain IBS151 (liaS) had a 1.7-fold-increased Gus activity compared to that of wild-type strain IBS131 (Fig. 3A). This increase in Gus activity is comparable with that of the single-crossover mutant IBS339, which resulted in an approximately twofold increase in Gus activity. On the other hand, no differences in activity were observed between the
liaR (IBS152) or
liaSR double mutant strain (IBS155) and wild-type strain IBS131.
![]() View larger version (37K): [in a new window] |
FIG. 3. Regulation of gbpC expression by SMu486/SMu487. (A) Expression from PgbpC-gusA was measured for the wild type, (IBS131); the SMu486 (IBS151), SMu487 (IBS152), and SMu486/SMu487 (IBS155) strains; the SMu486 strain complemented with pIB55 (IBS151/pIB55); and the single-crossover SMu486 strain (IBS339). Experiments were performed in triplicate, and the mean values with standard deviations are shown. (B) Expression from PgbpC-gusA was measured with the wild-type strain (IBS131) containing either pIB169 or pIB181, as described in the text. Experiments were performed in triplicate, and the mean values with standard deviations are shown. (C) Semiquantitative RT-PCR results showing the expression of gbpC from the wild type (UA159), the SMu486 mutant (IBS148), the SMu487 mutant (IBS149), and the SMu486 mutant complemented with pIB55 (IBS148/pIB55). The data are representative of RT-PCR analyses resulting from at least two different RNA isolations.
|
liaS), IBS149 (
liaR), and IBS183 (
liaSR) after growth reached mid-exponential phase. Semiquantitative RT-PCR was performed using gbpC-specific primers to measure the level of gbpC expression; the level of gyrA transcript produced was also measured to ensure that equal amounts of RNA were being used in the RT-PCR assay. As expected, the gbpC transcript level of IBS148 was about twofold higher than that of wild-type strain UA159 (Fig. 3C). This increased level of gbpC expression in the
liaS mutant strain was also observed for cultures grown to early stationary phase (data not shown), indicating that LiaS-mediated gbpC repression is growth phase independent. The levels of gbpC transcript produced from the other mutant strains were equivalent to those of wild-type strain UA159, consistent with the results of the PgbpC-gusA fusion reporter assays. To confirm that the observed increase in the expression of gbpC was due to the inactivation of liaS, the level of gbpC transcript produced was also measured in IBS148 and IBS151 transformed with pIB55, a plasmid containing the full-length liaSR operon (8). The level of gbpC transcript produced by the complemented strain was comparable to that of the wild-type strain (Fig. 3A and data not shown). Taken together, these results suggest that LiaS is involved in the regulation of gbpC expression. However, the role of the cognate response regulator LiaR in the regulation of gbpC is unclear. The overexpression of liaR from a heterologous promoter, Pveg, in IBS131, a wild-type strain that contains the PgbpC-gusA fusion reporter, did not lead to an increase in expression from PgbpC (Fig. 3B), suggesting that under the conditions tested, LiaR does not regulate the expression of gbpC; similar results were observed during semiquantitative RT-PCR analysis, as an increase in gbpC expression was not observed between the wild-type and LiaR-overexpressing strains (data not shown).
Mutacin IV production is down-regulated in the liaS mutant.
S. mutans has the capacity to produce mutacin, a bacteriocin, to suppress the growth of other competitor bacteria present in the dental plaque community (12, 19, 36, 38). In particular, S. mutans strain UA159 produces a mutacin that is active against sanguinis group and mitis group streptococci, the main competitors of S. mutans in the oral cavity (17, 18, 50). It was previously shown that both gbpC expression and mutacin production are modulated by the same regulatory network controlled by LuxS (35). Moreover, it was also shown that a regulatory gene for mutacin expression is present immediately upstream of gbpC (35). Therefore, it was of great interest to determine whether LiaS also regulates mutacin production. For these experiments, IBS148 (
liaS), IBS149 (
liaR), IBS183 (
liaSR), and the isogenic parental strain UA159 were subjected to deferred antagonism assays using S. cristatus (5100), and S. gordonii (DL-1) as indicator strains. As shown in Fig. 4A, the production of mutacin IV was drastically reduced in IBS148 but not in the other mutant strains. To verify that this effect was due to the inactivation of liaS, mutacin production was also measured in IBS148 transformed with pIB55. The level of production of mutacin was fully restored to the wild-type level in the complemented strain (Fig. 4A). Thus, in addition to gbpC, LiaS also appears to regulate mutacin production in S. mutans.
![]() View larger version (24K): [in a new window] |
FIG. 4. Regulation of mutacin IV production by SMu486 in S. mutans. (A) Deferred antagonism assay for mutacin IV production. S. mutans cultures were stabbed into THY agar and incubated overnight at 37°C under microaerophilic conditions. The plates were overlaid with soft agar containing the indicator strain. The zone of inhibition of the indicator strains was evaluated after overnight incubation. (B) Semiquantitative RT-PCR results showing the expression of nlmA and nlmT by the wild type (UA159), the SMu486 mutant (IBS148), and the SMu486 mutant complemented with pIB55 (IBS148/pIB55). The data are representative of RT-PCR analyses resulting from at least two different RNA isolations.
|
liaS mutant strain IBS148, suggesting that LiaS may also have a role in the regulation of nlmT expression. |
|
|---|
Although we found that LiaS controls gbpC expression, the cognate response regulator LiaR did not have any apparent effect on gbpC expression under the conditions tested. This phenomenon was also observed for mutacin IV production as well. The inactivation of liaS, whether through single- or double-crossover chromosomal integration, yielded similar results in our studies, suggesting that polar effects downstream of liaS were not a factor during single-crossover recombination. Moreover, semiquantitative RT-PCR analysis indicated that equivalent levels of LiaR were produced using either recombination technique (data not shown). It is surprising to find that only a mutation of the sensor kinase affected gbpC expression, while a mutation of the cognate response regulator did not have any noticeable effect. Although the mechanism is unclear, there are many precedents. For example, the inactivation of the sensor kinase of the TCS08 TCS of Streptococcus pneumoniae leads to the down-regulation of the genes involved with cellobiose utilization, but the inactivation of the cognate response regulator has no effect (34). Similarly, the inactivation of the CiaR response regulator of S. mutans has little effect on mutacin I production, whereas the inactivation of CiaH, the cognate sensor kinase, abolishes mutacin I production (39). Finally, in S. mutans, it was also reported previously that the inactivation of LiaS results in decreased acid tolerance, while the inactivation of LiaR does not affect acid tolerance (27).
While our results indicate that LiaS is involved in the regulation of gbpC expression, the role of LiaR is not immediately clear. A mutant strain containing inactivated liaR did not show significant differences in the level of expression of gbpC compared to that of the wild-type strain (Fig. 3), while the overexpression of liaR in a wild-type strain did not lead to significant increases in expression from PgbpC (Fig. 3B); this was also confirmed via semiquantitative RT-PCR analysis (data not shown). One possible explanation for our findings is that the phosphorylated form of LiaR is inactive and unable to activate the expression of gbpC; however, when the cognate sensor kinase LiaS is inactivated, LiaR is not phosphorylated, such that it is able to stimulate the transcription of gbpC. In the absence of LiaR (
liaR and
liaSR), the expression of gbpC is not observed. Further experimental studies will be required to confirm our speculation.
Another possible explanation could be that LiaS is involved in cross talk with a noncognate response regulator. In fact, recent reports in the literature support signal transduction from a sensor kinase to a noncognate response regulator in bacteria (40, 46, 51), and cross talk has also been suggested to be involved in the regulation of the S. mutans acid tolerance response by a TCS (27). A recently reported in vitro study suggested that approximately 50% of sensor kinases can cross talk with other response regulators in E. coli (53). Although the potential cross talk partners for LiaS were not identified in this study, there are several prospective candidates, such as SMu1008. The SMu1008/SMu1009 system, also known as MbrC/MbrD, belongs to the family of "bacitracin-responsive" TCS and is required for bacitracin resistance (49). The sensor kinase SMu1009 shows a high degree of similarity with LiaS and, like LiaS, contains a very short membrane-spanning domain (30). Thus, SMu1008 may cross talk with LiaS in addition to its role as the cognate response regulator for the sensor kinase SMu1009.
In contrast to the expression of gbpC, which is up-regulated in the
liaS mutant, the expression of nlmA is drastically reduced in the liaS mutant but was restored upon complementation with full-length liaS; as before, the inactivation of liaR did not have any noticeable effect on the expression of nlmA. This suggests that LiaS may act as a sensor kinase that stimulates either two distinct regulators with opposite functions or a single response regulator, such as LiaR, with different activities. There are several examples in the literature in which a single sensor kinase activates two different response regulators. For example, the CheA sensor kinase of E. coli has been shown to interact with CheB and CheY to regulate chemotaxis (26). On the other hand, response regulators with two disparate functions have also been identified. As an example, OmpR of E. coli functions both as an activator and as a repressor to differentially regulate the expression of the ompC and ompF genes (23, 37). Therefore, whether LiaS interacts with a single response regulator with opposing functions or with two different regulators remains to be studied. The expression of nlmT also appeared to be stimulated upon complementation with wild-type liaS, although the degree of expression was much lower than that with nlmA. Overall, the results suggest that LiaS is involved in the synthesis and export of mutacin IV in S. mutans.
In summary, we have shown that a putative regulatory locus, liaSR, may be important for the regulation of several virulence factors in S. mutans UA159. It was previously reported that the sensor kinase LiaS regulates the expression of genes involved in acid stress tolerance (8); our results indicated that LiaS also has a role in the regulation of expression of gbpC, which is essential for biofilm formation, and nlmA, which encodes one of the peptide components of mutacin IV. LiaS might also regulate other genes necessary for biofilm formation and cariogenesis, such that further studies are required to identify these genes. Furthermore, the function of LiaR is unclear and requires further experimental analysis to determine its physiological role in virulence and biofilm formation. A complete understanding of the LiaSR TCS and its regulon is essential in order to elucidate the regulation of virulence factors encoded by S. mutans and to gain a better understanding of the pathogenesis of disease induced by this organism.
Published ahead of print on 5 May 2008. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»